Consensus Embecta Corp.

Stocks

EMBC

US29082K1051

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2026-10-28 EDT			5-day change	1st Jan Change
6.460 ^USD	-1.37%		-3.29%	-45.62%

08-07	Tranche Update on Embecta Corp.'s Equity Buyback Plan announced on May 5, 2026.	CI
08-07	Embecta Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026	CI

Evolution of the Average Target: Embecta Corp.

Evolution of the Target Price: Embecta Corp.

Changes in Analyst Recommendations: Embecta Corp.

6c89293514.yW_CI6cLNb4rIm4juIcDDMU6E0nlqNf484lLRZI4Ifo.gwCodtI_Q_ZSbght9v1nO7JZXQKQ3qebwNMYHcUBFJidW4RF7TJ8jmdQLw~50b7e23c11aa2f8571e2705f13a31d9f

Analysts' recommendations: Embecta Corp.

05-18	BofA Securities Adjusts Price Target on Embecta to $3 From $11	MT
05-06	BTIG Downgrades Embecta to Neutral From Buy	MT
25-08-08	Medical supplies company Embecta beats Q3 estimates, raises FY forecast	RE
25-05-13	Morgan Stanley Adjusts Price Target on Embecta to $15 From $20, Maintains Equalweight Rating	MT
25-04-10	Mizuho Initiates Embecta at Neutral With $15 Price Target	MT
24-12-02	Morgan Stanley Upgrades Embecta to Equalweight, Price Target is $20	MT
24-11-27	BTIG Research Upgrades Embecta to Buy From Neutral, $26 Price Target	MT
24-07-15	Morgan Stanley Lowers Price Target on Embecta to $12 From $13, Maintains Underweight Rating	MT
23-11-22	Morgan Stanley Adjusts Price Target on to $16 From $15, Maintains Underweight Rating	MT
23-10-18	Morgan Stanley Adjusts Price Target on Embecta to $15 From $16, Maintains Underweight Rating	MT
23-10-18	BofA Trims Price Target on Embecta to $17 From $25, Keeps Underperform Rating	MT
23-08-24	Morgan Stanley Trims Price Target on Embecta to $16 From $19, Maintains Underweight Rating	MT
23-07-18	Morgan Stanley Adjusts Price Target on Embecta to $19 From $29, Maintains Underweight Rating	MT
23-01-06	Morgan Stanley Downgrades Embecta to Underweight From Equalweight, Price Target is $28	MT
22-12-21	Morgan Stanley Adjusts Price Target on Embecta to $31 From $33, Maintains Equal-Weight Rating	MT
22-10-11	Morgan Stanley Adjusts Price Target on Embecta Corp. to $33 From $36, Reiterates Equalweight Rating	MT
22-09-08	BTIG Initiates Embecta at Neutral	MT
22-08-16	Morgan Stanley Adjusts Price Target on Embecta to $36 From $33, Keeps Equalweight Rating	MT
22-08-01	Morgan Stanley Initiates Embecta at Equalweight with $33 Price Target	MT
22-06-21	BofA Securities Initiates Embecta at Underperform with $25 Price Target	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	EMBECTA CORP.					-38.93%
	ABBOTT LABORATORIES					+14.96%
	STRYKER CORPORATION					+20.3%
	MEDTRONIC PLC					+11.35%
	ESSILORLUXOTTICA					+18.76%
	CENCORA, INC.					+13.44%
	HOYA CORPORATION					+16.14%
	BECTON, DICKINSON AND COMPANY					+0.28%
	IDEXX LABORATORIES, INC.					+23.73%
	ALCON INC.					+30.6%
	Average					+11.06%
	Weighted average by Cap.					+15.81%